Annual Retained Earnings
-$340.52 M
+$275.19 M+44.69%
December 31, 2024
Summary
- As of March 14, 2025, PTGX annual retained earnings is -$340.52 million, with the most recent change of +$275.19 million (+44.69%) on December 31, 2024.
- During the last 3 years, PTGX annual retained earnings has risen by +$68.84 million (+16.82%).
- PTGX annual retained earnings is now -2611.59% below its all-time high of -$12.56 million, reached on December 31, 2014.
Performance
PTGX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$340.52 M
+$131.67 M+27.89%
December 31, 2024
Summary
- As of March 14, 2025, PTGX quarterly retained earnings is -$340.52 million, with the most recent change of +$131.67 million (+27.89%) on December 31, 2024.
- Over the past year, PTGX quarterly retained earnings has increased by +$131.67 million (+27.89%).
- PTGX quarterly retained earnings is now -1142.06% below its all-time high of -$27.42 million, reached on December 31, 2015.
Performance
PTGX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PTGX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.7% | +27.9% |
| 3 y3 years | +16.8% | +27.9% |
| 5 y5 years | -56.5% | +27.9% |
PTGX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | at high | +47.0% |
| 5 y | 5-year | -56.5% | +44.7% | -56.5% | +47.0% |
| alltime | all time | -2611.6% | +44.7% | -1142.1% | +47.0% |
Protagonist Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$340.52 M(-44.7%) | -$340.52 M(-27.9%) |
| Sep 2024 | - | -$472.20 M(+7.6%) |
| Jun 2024 | - | -$438.99 M(+7.5%) |
| Mar 2024 | - | -$408.37 M(-33.7%) |
| Dec 2023 | -$615.71 M(+14.7%) | -$615.71 M(-4.3%) |
| Sep 2023 | - | -$643.04 M(+5.6%) |
| Jun 2023 | - | -$608.94 M(+6.7%) |
| Mar 2023 | - | -$570.48 M(+6.3%) |
| Dec 2022 | -$536.75 M(+31.1%) | -$536.75 M(+6.8%) |
| Sep 2022 | - | -$502.56 M(+6.6%) |
| Jun 2022 | - | -$471.33 M(+9.5%) |
| Mar 2022 | - | -$430.29 M(+5.1%) |
| Dec 2021 | -$409.36 M(+44.2%) | -$409.36 M(+9.9%) |
| Sep 2021 | - | -$372.45 M(+10.0%) |
| Jun 2021 | - | -$338.65 M(+10.0%) |
| Mar 2021 | - | -$307.81 M(+8.5%) |
| Dec 2020 | -$283.81 M | -$283.81 M(+7.1%) |
| Sep 2020 | - | -$264.93 M(+3.0%) |
| Jun 2020 | - | -$257.16 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$237.74 M(+9.2%) |
| Dec 2019 | -$217.66 M(+54.9%) | -$217.66 M(+8.7%) |
| Sep 2019 | - | -$200.16 M(+8.9%) |
| Jun 2019 | - | -$183.75 M(+18.9%) |
| Mar 2019 | - | -$154.58 M(+10.0%) |
| Dec 2018 | -$140.47 M(+38.3%) | -$140.47 M(+11.0%) |
| Sep 2018 | - | -$126.61 M(+7.4%) |
| Jun 2018 | - | -$117.87 M(+7.9%) |
| Mar 2018 | - | -$109.21 M(+7.5%) |
| Dec 2017 | -$101.55 M(+57.2%) | -$101.55 M(+3.1%) |
| Sep 2017 | - | -$98.50 M(+5.2%) |
| Jun 2017 | - | -$93.67 M(+19.0%) |
| Mar 2017 | - | -$78.69 M(+21.8%) |
| Dec 2016 | -$64.59 M(+135.6%) | -$64.59 M(+21.1%) |
| Sep 2016 | - | -$53.34 M(+15.3%) |
| Jun 2016 | - | -$46.26 M(+18.1%) |
| Mar 2016 | - | -$39.16 M(+42.8%) |
| Dec 2015 | -$27.42 M(+118.3%) | -$27.42 M |
| Dec 2014 | -$12.56 M | - |
FAQ
- What is Protagonist Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual retained earnings year-on-year change?
- What is Protagonist Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
What is Protagonist Therapeutics annual retained earnings?
The current annual retained earnings of PTGX is -$340.52 M
What is the all time high annual retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual retained earnings is -$12.56 M
What is Protagonist Therapeutics annual retained earnings year-on-year change?
Over the past year, PTGX annual retained earnings has changed by +$275.19 M (+44.69%)
What is Protagonist Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PTGX is -$340.52 M
What is the all time high quarterly retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly retained earnings is -$27.42 M
What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PTGX quarterly retained earnings has changed by +$131.67 M (+27.89%)